AIM2 and renal carcinoma: In the present study, we constructed CAIXpromotor controlled oncolytic adenovirus expressing AIM2 (Ad‐CAIXpromotor‐AIM2) and evaluated its efficacy and toxicity in renal cancer cells or tumour models.